Literature DB >> 10411434

All patients with small intramural rectal cancers are at risk for lymph node metastasis.

D Blumberg1, P B Paty, J G Guillem, A I Picon, B D Minsky, W D Wong, A M Cohen.   

Abstract

PURPOSE: Although local excision can be curative in patients with early-stage rectal cancer, approximately 20 percent of patients will develop local recurrence, many as a result of unrecognized and unresected regional lymph node metastases. Our objective was to determine if standard pathologic factors can predict lymph node metastases in small intramural rectal cancers and provide a basis for patient selection for nonradical surgery.
METHODS: Between June 1986 and September 1996, 318 patients with T1 or T2 rectal cancers underwent radical resection at our institution. Of these, 159 patients (48 T1 and 111 T2) were potentially eligible for curative local excision (< or =4 cm in size, < or =10 cm from the anal verge, no synchronous metastases), and the prevalence of lymph node metastases based on T stage and other pathologic factors was analyzed in this group.
RESULTS: The overall frequency of lymph node metastasis was 15 percent (24/159 patients). T stage (T1, 10 percent; T2, 17 percent), differentiation (well-differentiated or moderately differentiated, 14 percent and poorly differentiated, 30 percent), and lymphatic vessel invasion (lymphatic vessel invasion-negative, 14 percent and lymphatic vessel invasion-positive, 33 percent) influenced the risk of lymph node metastasis. However, only blood vessel invasion (blood vessel invasion-negative, 13 percent and blood vessel invasion-positive, 33 percent) reached statistical significance as a single predictive factor (P=0.04). Tumors with no adverse pathologic features (low-risk group) had a lower overall frequency of lymph node metastasis (11 percent) compared with the remaining tumors (high-risk group, 31 percent; P=0.008). However, even in the most favorable group (T1 cancers with no adverse pathologic features) lymph node metastases were present in 7 percent of patients.
CONCLUSION: In rectal cancer patients potentially eligible for local excision, the overall risk of undetected and untreated lymph node metastases is considerable (15 percent). The use of pathologic factors alone after local excision does not reliably assure the absence of lymph node metastases.

Entities:  

Mesh:

Year:  1999        PMID: 10411434     DOI: 10.1007/bf02237095

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  30 in total

Review 1.  Transanal Minimally Invasive Surgery: State of the Art.

Authors:  D S Keller; E M Haas
Journal:  J Gastrointest Surg       Date:  2015-11-25       Impact factor: 3.452

2.  Oncological outcomes of transanal local excision for high risk T(1) rectal cancers.

Authors:  Ze-Yu Wu; Gang Zhao; Zhe Chen; Jia-Lin Du; Jin Wan; Feng Lin; Lin Peng
Journal:  World J Gastrointest Oncol       Date:  2012-04-15

3.  Local treatment for rectal cancer.

Authors:  Daniel P Geisler
Journal:  Clin Colon Rectal Surg       Date:  2007-08

4.  Outcomes for early rectal cancer managed with transanal endoscopic microsurgery: a 5-year follow-up study.

Authors:  F Stipa; A Burza; G Lucandri; M Ferri; A Pigazzi; V Ziparo; G Casula; S Stipa
Journal:  Surg Endosc       Date:  2006-02-27       Impact factor: 4.584

5.  Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?

Authors:  R Hughes; R Glynne-Jones; J Grainger; P Richman; A Makris; M Harrison; R Ashford; R A Harrison; J I Livingstone; P J McDonald; J Meyrick Thomas; I C Mitchell; J M A Northover; R Phillips; M Wallace; A Windsor; J R Novell
Journal:  Int J Colorectal Dis       Date:  2005-04-30       Impact factor: 2.571

6.  Local management of rectal neoplasia.

Authors:  John Touzios; Kirk A Ludwig
Journal:  Clin Colon Rectal Surg       Date:  2008-11

7.  Outcomes of Local Excision plus Chemoradiotherapy in Patients with T1 Rectal Cancer.

Authors:  Toshiyuki Suzuki; Sotaro Sadahiro; Akira Tanaka; Kazutake Okada; Gota Saito; Hiroshi Miyakita; Takeshi Akiba; Hiroshi Yamamuro
Journal:  Oncology       Date:  2018-06-15       Impact factor: 2.935

8.  Laparoscopic radioisotope-guided sentinel lymph node mapping and excision of the rectum--an experimental study.

Authors:  S Shah; A Scholz; H Reber; M Schreckenberger; R Viebahn; H Lang; M Korenkov
Journal:  Langenbecks Arch Surg       Date:  2009-03-10       Impact factor: 3.445

9.  Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database.

Authors:  Y Nancy You; Nancy N Baxter; Andrew Stewart; Heidi Nelson
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

10.  Radical surgery for early colorectal cancer--anachronism or oncologic necessity?

Authors:  Franz Georg Bader; Uwe Johannes Roblick; Elisabeth Oevermann; Hans-Peter Bruch; Oliver Schwandner
Journal:  Int J Colorectal Dis       Date:  2008-04       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.